Explore

Medical Societies Issue Fall Vaccination Guidelines Amidst CDC Advisory Panel Court Battle

Medical Societies Issue Fall Vaccination Guidelines Amidst CDC Advisory Panel Court Battle

Medical experts are urging the public to get vaccinated against influenza, COVID-19, and RSV, with October and November identified as ideal times for flu shots. This year, major medical societies, including the American Academy of Pediatrics, American Academy of Family Physicians, American College of Obstetricians and Gynecologists, and the Infectious Diseases Society of America, have released their own vaccination guidelines. This action comes as the Centers for Disease Control and Prevention (CDC) has not updated its flu advice due to its independent advisory panel being involved in a court battle. These medical groups are filling the void by providing scientific evidence-backed recommendations for their patient populations. They emphasize that while vaccines do not guarantee prevention of illness, they significantly reduce the risk of severe outcomes, hospitalizations, and deaths. Flu alone causes hundreds of thousands of hospitalizations and tens of thousands of deaths in the U.S. annually.

KFF Dashboard Provides Ongoing Data on U.S. Vaccine Attitudes and Knowledge

KFF Dashboard Provides Ongoing Data on U.S. Vaccine Attitudes and Knowledge

The KFF (formerly Kaiser Family Foundation) is providing ongoing, current data on U.S. vaccine attitudes and knowledge through its KFF Health Information and Trust Polling Dashboard. This resource builds upon the earlier KFF COVID-19 Vaccine Monitor Dashboard, which focused specifically on COVID-19 vaccines and concluded its most recent surveys in late 2023. The updated dashboard now covers a broader range of vaccine-related topics, including public trust in health information sources, confidence in federal health agencies, and parental trust in childhood vaccines. KFF, a nonprofit organization funded by an endowment and external donors, primarily focuses on U.S. populations across various health topics. Their data also tracks awareness of and belief in false or unproven health claims, such as misconceptions about mRNA vaccine safety or the efficacy of Vitamin A against measles. Ongoing tracking polls provide insights into Americans' views on vaccine safety from April 2025 through June 2026, with data coll...

Moderna lifts annual revenue forecast on strong COVID vaccine demand overseas

Moderna lifts annual revenue forecast on strong COVID vaccine demand overseas

Nov 6 (Reuters) - Moderna lifted its full-year revenue forecast on Friday, after strong international demand for its COVID-19 vaccine and payments from partnerships helped the biotech swing to profit in the third quarter.

Merck and Moderna Demonstrate High Manufacturing Success for Personalized mRNA Cancer Vaccine in Phase 3 Trial

Merck and Moderna Demonstrate High Manufacturing Success for Personalized mRNA Cancer Vaccine in Phase 3 Trial

Merck and Moderna have reported significant success in the manufacturing and delivery of their personalized mRNA cancer vaccine, intismeran autogene, during the Phase 3 INTerpath-001 trial for high-risk melanoma. The companies successfully provided the custom-made vaccine to 99% of patients in the treatment arm, demonstrating the feasibility of deploying this complex, individualized therapy on a large scale. This achievement is crucial because these vaccines are custom-made for each patient using samples from their unique tumors obtained during resection. The manufacturing process involves sequencing patient tumor tissue to identify specific mutational signatures, then writing a personalized synthetic mRNA code for up to 34 neoantigens. This code instructs the immune system on how to combat the unique cancer. The trial, which included 1,137 patients with resected stage 2b to 4 melanoma, also showed that the vaccine, when paired with Merck’s Keytruda, reduced the risk of recurrence or death by 42%. The stud...

New Research Links Energy Drinks and Stimulant Supplements to Increased Heart Risks in Young Adults

New Research Links Energy Drinks and Stimulant Supplements to Increased Heart Risks in Young Adults

Preliminary research indicates a significant association between energy drinks, stimulant supplements, and serious heart problems in young adults. The study, which analyzed over 28,000 adverse event reports submitted to the Food and Drug Administration (FDA) between 2017 and 2025, found that cardiac arrest was reported approximately 11 times more often with energy drinks and stimulant supplements compared to non-stimulant products. Heart attacks were reported 4.5 times more frequently, and ventricular arrhythmias and palpitations about four times more often. Nearly 45% of these heart-related reports involved adults aged 18 to 34. These findings, to be presented at the American Heart Association (AHA) Scientific Sessions 2026, suggest that while occasional consumption might pose minimal risk for healthy individuals, regular use could lead to cardiovascular harm, especially given that some energy drinks contain up to three times more caffeine per fluid ounce than brewed coffee, alongside other stimulants lik...

Personalized mRNA Cancer Vaccine Shows Promising Phase 3 Results for High-Risk Melanoma Patients

Personalized mRNA Cancer Vaccine Shows Promising Phase 3 Results for High-Risk Melanoma Patients

A personalized messenger RNA (mRNA) cancer vaccine, intismeran autogene, combined with pembrolizumab (Keytruda), has met key endpoints in a Phase 3 trial for patients with high-risk melanoma who have undergone surgery. The international INTerpath-001 trial investigated whether this investigational mRNA-based individualized vaccine could enhance the immune response against residual cancer cells. The study involved 1,137 patients with completely resected stage 2B-4 cutaneous melanoma who had not previously received systemic therapy. Patients were randomized to receive either intismeran autogene plus pembrolizumab or pembrolizumab alone. In a prespecified interim analysis, the combination therapy met the primary endpoint of recurrence-free survival and a key secondary endpoint of distant metastasis-free survival, showing statistically significant improvements compared to pembrolizumab alone. Detailed results, including numerical effect estimates and longer-term outcomes, are expected to be presented at a fort...

CDC Recommends Annual Flu Vaccination for All Individuals Six Months and Older

CDC Recommends Annual Flu Vaccination for All Individuals Six Months and Older

The Centers for Disease Control and Prevention (CDC) advises annual influenza vaccination for all individuals aged six months and older, unless specific contraindications exist. This recommendation is a cornerstone of public health efforts to combat the seasonal flu. People who are unsure if they have received an influenza vaccine during the current season are encouraged to get vaccinated. Healthcare providers are required by federal law to furnish Vaccine Information Statements (VISs) to patients, parents, or legal representatives in their primary language before administering the vaccine. These statements detail the benefits and risks associated with the vaccination. For children aged six months through eight years, a second flu vaccine dose is recommended at least four weeks after the first if they are receiving an influenza vaccine for the first time, have not previously received at least two doses of any seasonal influenza vaccine before July 1 of the current year, or have an unknown vaccination histo...

Moderna Reports Q3 2026 Profit, Signaling Shift from Consistent Losses

Moderna Reports Q3 2026 Profit, Signaling Shift from Consistent Losses

Moderna Reports Q3 2026 Profit, Signaling Shift from Consistent Losses

Federal Agencies Collaborate on Consumer Protection, Addressing Deceptive Practices and Product Safety

Federal Agencies Collaborate on Consumer Protection, Addressing Deceptive Practices and Product Safety

Multiple federal agencies are actively involved in consumer protection, each with specific legal authority over different aspects of the market. The Federal Trade Commission (FTC) focuses on deceptive and unfair practices, including inadequately supported advertising claims. The Consumer Product Safety Commission (CPSC) addresses hazards in consumer products within its jurisdiction. The Food and Drug Administration (FDA) covers specific categories such as food, drugs, cosmetics, and medical devices. The Consumer Financial Protection Bureau (CFPB) handles financial products and services. These agencies' responsibilities and enforcement tools vary, and their authority is established by enabling statutes. Overlapping jurisdiction can occur, meaning several agencies might have authority over different aspects of a single underlying matter, requiring each to verify its specific powers before acting. For instance, a lead-paint toy case could involve both the CPSC for physical safety and the FTC for misleading ad...

Moderna Raises 2026 Outlook Amid Stronger Vaccine Sales and Cost Reductions

Moderna Raises 2026 Outlook Amid Stronger Vaccine Sales and Cost Reductions

Moderna Raises 2026 Outlook Amid Stronger Vaccine Sales and Cost Reductions

Senator Duckworth Seeks FDA Clarification on Estradiol Transdermal Patch Shortage

Senator Duckworth Seeks FDA Clarification on Estradiol Transdermal Patch Shortage

U.S. Senator Tammy Duckworth (D-IL) has formally requested that federal regulators clarify their plans to mitigate an ongoing shortage of estradiol transdermal patches. According to Senator Duckworth, this shortage is making it more difficult for women to effectively manage the symptoms associated with menopause. Her inquiry to the Food and Drug Administration (FDA) seeks detailed information on the root causes of the supply disruption and the specific actions the agency intends to take to resolve the issue and ensure consistent availability of this critical medication.

Energy Drinks and Stimulant Supplements Linked to Acute Cardiovascular Events in Young Consumers

Energy Drinks and Stimulant Supplements Linked to Acute Cardiovascular Events in Young Consumers

New study results presented at the American Heart Association (AHA) Scientific Sessions 2026 in Chicago indicate a disproportionate reporting of acute cardiovascular events associated with caffeine- and stimulant-containing energy drinks and dietary supplements. Investigators reviewed data from the U.S. Food and Drug Administration’s (FDA) Center for Food Safety and Applied Nutrition Adverse Event Reporting System. The analysis compared cardiovascular event reports for products containing caffeine, methylxanthines (like guarana and green tea extracts), sympathomimetics (such as yohimbine and ephedra), and popular caffeinated brands (including Celsius, Red Bull, Monster, and Rockstar) against other orally consumed products. The study found that 8 out of 10 cardiovascular outcomes achieved statistical signal thresholds, with the strongest signal for cardiac arrest, followed by myocardial infarction, ventricular arrhythmia, and palpitations. These findings suggest a significant link between these products and...